BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 23164592)

  • 41. ASPIRE registry: assessing the Spectrum of Pulmonary hypertension Identified at a REferral centre.
    Hurdman J; Condliffe R; Elliot CA; Davies C; Hill C; Wild JM; Capener D; Sephton P; Hamilton N; Armstrong IJ; Billings C; Lawrie A; Sabroe I; Akil M; O'Toole L; Kiely DG
    Eur Respir J; 2012 Apr; 39(4):945-55. PubMed ID: 21885399
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Survival in patients with pulmonary arterial hypertension treated with first-line bosentan.
    McLaughlin VV
    Eur J Clin Invest; 2006 Sep; 36 Suppl 3():10-5. PubMed ID: 16919005
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The pulmonary arterial hypertension quality enhancement research initiative: comparison of patients with idiopathic PAH to patients with systemic sclerosis-associated PAH.
    Clements PJ; Tan M; McLaughlin VV; Oudiz RJ; Tapson VF; Channick RN; Rubin LJ; Langer A;
    Ann Rheum Dis; 2012 Feb; 71(2):249-52. PubMed ID: 21998119
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessing pulmonary hypertensive vascular disease in childhood. Data from the Spanish registry.
    del Cerro Marín MJ; Sabaté Rotés A; Rodriguez Ogando A; Mendoza Soto A; Quero Jiménez M; Gavilán Camacho JL; Raposo Sonnenfeld I; Moya Bonora A; Albert Brotons DC; Moreno Galdó A;
    Am J Respir Crit Care Med; 2014 Dec; 190(12):1421-9. PubMed ID: 25379685
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model.
    Hoeper MM; Kramer T; Pan Z; Eichstaedt CA; Spiesshoefer J; Benjamin N; Olsson KM; Meyer K; Vizza CD; Vonk-Noordegraaf A; Distler O; Opitz C; Gibbs JSR; Delcroix M; Ghofrani HA; Huscher D; Pittrow D; Rosenkranz S; Grünig E
    Eur Respir J; 2017 Aug; 50(2):. PubMed ID: 28775047
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of patients with pulmonary arterial hypertension at the time of death or deterioration to functional class IV: insights from the REVEAL Registry.
    Farber HW; Miller DP; Meltzer LA; McGoon MD
    J Heart Lung Transplant; 2013 Nov; 32(11):1114-22. PubMed ID: 24035189
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic impact of pulmonary arterial hypertension: a population-based analysis.
    Carrington M; Murphy NF; Strange G; Peacock A; McMurray JJ; Stewart S
    Int J Cardiol; 2008 Feb; 124(2):183-7. PubMed ID: 17433474
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Pulmonary arterial hypertension in the elderly subject].
    Frachon I; Barnier A; Jobic Y; Gut-Gobert C; Etienne Y; Crutu A; Mialon P; Pasquier E; Nowak E; Mejri M; Couturaud F; Leroyer C;
    Rev Mal Respir; 2010; 27(1):30-6. PubMed ID: 20146949
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic factors associated with increased survival in patients with pulmonary arterial hypertension treated with subcutaneous treprostinil in randomized, placebo-controlled trials.
    Benza RL; Gomberg-Maitland M; Naeije R; Arneson CP; Lang IM
    J Heart Lung Transplant; 2011 Sep; 30(9):982-9. PubMed ID: 21531577
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sildenafil improves survival in idiopathic pulmonary arterial hypertension.
    Sastry BK; Raju BS; Narasimhan C; Prakash GS; Reddy NK; Ananad B
    Indian Heart J; 2007; 59(4):336-41. PubMed ID: 19126939
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Survival in pulmonary hypertension in Spain: insights from the Spanish registry.
    Escribano-Subias P; Blanco I; López-Meseguer M; Lopez-Guarch CJ; Roman A; Morales P; Castillo-Palma MJ; Segovia J; Gómez-Sanchez MA; Barberà JA;
    Eur Respir J; 2012 Sep; 40(3):596-603. PubMed ID: 22362843
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Congenital heart disease-associated pulmonary arterial hypertension: preliminary results from a novel registry.
    Rose ML; Strange G; King I; Arnup S; Vidmar S; O'Donnell C; Kermeen F; Grigg L; Weintraub RG; Celermajer DS
    Intern Med J; 2012 Aug; 42(8):874-9. PubMed ID: 22212153
    [TBL] [Abstract][Full Text] [Related]  

  • 53. BMPR2 mutations influence phenotype more obviously in male patients with pulmonary arterial hypertension.
    Liu D; Wu WH; Mao YM; Yuan P; Zhang R; Ju FL; Jing ZC
    Circ Cardiovasc Genet; 2012 Oct; 5(5):511-8. PubMed ID: 22923421
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical outcomes of pulmonary arterial hypertension in carriers of BMPR2 mutation.
    Sztrymf B; Coulet F; Girerd B; Yaici A; Jais X; Sitbon O; Montani D; Souza R; Simonneau G; Soubrier F; Humbert M
    Am J Respir Crit Care Med; 2008 Jun; 177(12):1377-83. PubMed ID: 18356561
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effectiveness of transition from intravenous epoprostenol to oral/inhaled targeted pulmonary arterial hypertension therapy in pediatric idiopathic and familial pulmonary arterial hypertension.
    Melnick L; Barst RJ; Rowan CA; Kerstein D; Rosenzweig EB
    Am J Cardiol; 2010 May; 105(10):1485-9. PubMed ID: 20451700
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Survival of patients with idiopathic pulmonary arterial hypertension after listing for transplantation: impact of iloprost and bosentan treatment.
    Dandel M; Lehmkuhl HB; Mulahasanovic S; Weng Y; Kemper D; Grauhan O; Knosalla C; Hetzer R
    J Heart Lung Transplant; 2007 Sep; 26(9):898-906. PubMed ID: 17845928
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Management and prognosis of HIV-associated pulmonary arterial hypertension: 20 Years of evidence from the REHAP registry.
    Salvador ML; Rodríguez-Padial L; Soto Abánades C; Cruz Utrilla A; Barberá Mir JA; López-Meseguer M; Segovia Cubero J; Samper GJ; Blanco Vich I; Escribano-Subías P; ;
    J Intern Med; 2022 Jul; 292(1):116-126. PubMed ID: 35184348
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of baseline predictors of prognosis in pulmonary arterial hypertension in patients surviving ≤2 years and those surviving ≥5 years after baseline right-sided cardiac catheterization.
    Batal O; Khatib OF; Dweik RA; Hammel JP; McCarthy K; Minai OA
    Am J Cardiol; 2012 May; 109(10):1514-20. PubMed ID: 22360818
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hemodynamics and survival of patients with portopulmonary hypertension.
    Kawut SM; Taichman DB; Ahya VN; Kaplan S; Archer-Chicko CL; Kimmel SE; Palevsky HI
    Liver Transpl; 2005 Sep; 11(9):1107-11. PubMed ID: 16123953
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Seven years of experience in patients with pulmonary arterial hypertension in Ege University Hospital: diagnostic approach of a single center].
    Kayikçioğlu M; Kültürsay H
    Anadolu Kardiyol Derg; 2008 Aug; 8(4):279-85. PubMed ID: 18676304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.